Operating Lease, Right-of-Use Asset of Sionna Therapeutics, Inc. from 31 May 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sionna Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 May 2022 to 31 Dec 2025.
  • Sionna Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $6,926,000, a 12% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sionna Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $6,926,000 -$906,000 -12% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 $7,165,000 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $7,395,000 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $7,617,000 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $7,832,000 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q2 2022 $9,500,000 31 May 2022 10-K 02 Mar 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.